Kathryn Stein compensation by year
Genpact Summary Compensation Table · all 3 fiscal years held| Component | FY2020 | FY2021 | FY2023 |
|---|---|---|---|
| Salary | $462,062 | $550,000 | $650,000 |
| Bonus | $0 | $0 | $650,000 |
| Stock awards | $984,864 | $1,237,726 | $1,798,393 |
| Option awards | $1,048,765 | $999,995 | $0 |
| Non-equity incentive | $459,214 | $662,920 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $12,544 | $12,860 | $15,108 |
| Total | $2,967,449 | $3,463,501 | $3,113,501 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Genpact LTD DEF 14A filed March 20, 2024, accession 0001140361-24-014255, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Genpact LTD filed document, accession 0001140361-24-014255. Every figure is read from that document and cited to the page and table it appears in. Filed March 20, 2024.
Equity holdings
unvested awards at FY2023 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 36,657 | $1,272,364 | — |
| PSU | 30,937 | $1,073,823 | — |
| RSU | 27,442 | $952,512 | — |
| RSU | 9,878 | $342,865 | — |
| Option | 53,991 | — | $43.94 |
| Option | 98,802 | — | $39.97 |
| Option | 96,518 | — | $52.12 |
| Option | 84,051 | — | $27.70 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Genpact LTD's FY2023 proxy; value at the fiscal year-end close, as the company printed it.
Change-in-control & termination
estimated payments Genpact discloses, by trigger · FY2023| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Death | $0 | $2,379,617 | $0 | $2,379,617 |
| Involuntary termination without cause | $1,063,562 | $1,975,858 | $36,176 | $3,075,596 |
| Resignation for good reason, no change in control | $1,063,562 | $1,975,858 | $36,176 | $3,075,596 |
| Change in control and involuntary termination | $0 | $4,230,805 | $0 | $4,230,805 |
| Retirement | $0 | $472,206 | $0 | $472,206 |
| Disability | $0 | $2,379,617 | $0 | $2,379,617 |
| Involuntary for cause | $0 | $0 | $0 | $0 |
Per the Potential Payments Upon Termination or Change in Control table in Genpact LTD's FY2023 proxy. Estimates as the company printed them; a dash means it printed no figure.
Genpact’s named executive officers, FY2023
as the company reported each| Named executive officer | Role | FY2023 total |
|---|---|---|
| N.v. Tyagarajan | President, Chief Executive Officer and Director | $9,987,346 |
| Balkrishan Kalra | Senior Vice President, Banking, Capital Markets, Consumer Goods, Retail, Life Sciences and Healthcare | $3,952,241 |
| Michael Weiner | Senior Vice President, Chief Financial Officer | $3,170,571 |
| Kathryn Stein · this page | Senior Vice President, Chief Strategy Officer and Global Business Leader, Enterprise Services and Analytics | $3,113,501 |
| Piyush Mehta | Senior Vice President, Chief Human Resources Officer | $2,097,001 |
The full Genpact compensation record
free company briefThis page is one person within Genpact's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Genpact proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Genpact's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.